We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Focuses on Clinical Trials for Acne Treatments
FDA Guidance Focuses on Clinical Trials for Acne Treatments
September 16, 2005
Pharmaceutical firms developing treatments for chronic acne should design clinical studies with co-primary endpoints that evaluate both acne lesion counts and an investigator’s global assessment (IGA) scale of overall acne severity, according to a new FDA draft guidance.